Filter
Reset all

Subjects

Content Types

Countries

API

Data access

Database access

Database licenses

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 2 result(s)

Nuclear Data Portal

Subject(s)
Content type(s)
Country
The Nuclear Data Portal is a new generation of nuclear data services using modern and powerful DELL servers, Sybase relational database software, the Linux operating system with programming in Java. The Portal includes nuclear structure, decay and reaction data, as well as literature information. Data can be searched for using optimized query forms; results are presented in tables and interactive plots. Additionally, a number of nuclear science tools, codes, applications, and links are provided. The databases includes are: CINDA - Computer Index of Nuclear Reaction Data, CSISRS alias EXFOR - Experimental nuclear reaction data, ENDF - Evaluated Nuclear Data File , ENSDF - Evaluated Nuclear Structure Data File, MIRD - Medical Internal Radiation Dose, NSR - Nuclear Science References, NuDat - Nuclear Structure & Decay Data, XUNDL - Experimental Unevaluated Nuclear Data List, Chart of Nuclides. Nuclear Data Portal is a web service of National Nuclear Data Center.

ChEMBL

Subject(s)
Content type(s)
Country
ChEMBL is a database of bioactive drug-like small molecules, it contains 2-D structures, calculated properties (e.g. logP, Molecular Weight, Lipinski Parameters, etc.) and abstracted bioactivities (e.g. binding constants, pharmacology and ADMET data). The data is abstracted and curated from the primary scientific literature, and cover a significant fraction of the SAR and discovery of modern drugs We attempt to normalise the bioactivities into a uniform set of end-points and units where possible, and also to tag the links between a molecular target and a published assay with a set of varying confidence levels. Additional data on clinical progress of compounds is being integrated into ChEMBL at the current time.